Medical Index
This index characterizes indications and diseases for products in
Biopharmaceuticals in the U.S. and European Markets.
- abdominal cancer treatment -- 131
- ablation, thyroid cancer radiotreatment -- 262
- abscesses -- 219
- acid maltase deficiency -- 168
- acromegaly treatment -- 259
- actinic keratosis -- 260
- acute ischemic stroke -- 269
- acute myocardial infarction (AMI) -- 118; 268; 269; 270; 274; 606; 624; 625; 626; 627
- acute respiratory distress syndrome (ARDS) -- 940
- adenoside deaminase (ADA) deficiency -- 605
- adenovirus infection prophylaxis -- 401; 402; 403
- adhesive, surgical -- 900
- agammaglobulinemia -- 758; 760; 761; 765; 767; 768; 771
- age-related macular degeneration (AMD) -- 275; 276; 949
- AIDS wasting -- 257
- alpha1-antitrypsin deficiency (A1AD) -- 709; 710; 711; 712
- amyotrophic lateral sclerosis (ALS) -- 200
- anastomoses, sealing -- 900
- anemia -- 132; 133; 134; 135; 136; 137; 138; 139; 140; 141; 142; 143; 702; 741; 902; 918
- angina -- 240
- angiogenesis inhibitors -- 129; 130; 275; 275; 276; 949
- angioplasty -- 240; 934
- ankylosing spondylitis -- 264
- anovulation -- 155; 156; 157
- anthrax prophylaxis -- 103; 104; 404
- anthrax treatment -- 744; 745; 746
- anticoagulation -- 180; 181; 182; 934
- antiinflammation -- 227
- antithrombin III deficiency -- 102; 706; 707; 708
- aplastic anemia -- 918
- apoptosis inhibition -- 945
- appendicitis, radiodiagnosis -- 305
- arthritis, juvenile idiopathic -- 223
- arthritis, psoriatic -- 264; 265; 267
- arylsulfatase B deficiency -- 105
- asparaginase deficiency -- 607; 608; 609; 611
- Assisted Reproductive Technology (ART) -- 155; 156; 157; 172; 228
- asthma, allergic -- 189
- autism -- 935; 936; 939
- autoimmune disorders -- 120; 227; 948
- Bacillus anthracis prophylaxis -- 103; 104; 404
- bacteremia, Staphylococcus aureus -- 542
- bacterial infections, Gram negative -- 243
- Bcl-2 messenger RNA (mRNA) inhibition -- 945
- Behcet's disease -- 264
- black widow spider bites -- 909
- blepharospasm -- 601; 603
- blood chromatography -- 700
- blood progenitor cell transplants -- 169; 170; 171
- blood transfusion -- 702
- blood-brain barrier blockage -- 203
- bone calcium metabolism -- 110
- bone fracture repair -- 107; 108; 109
- bone marrow transplantation (BMT) -- 169; 170; 171; 226; 761; 765
- bone repair, periodontal -- 237; 931
- botulism -- 413; 911; 912
- brain cancer -- 217; 416
- breast cancer -- 179
- bronchopulmonary dysplasia (BPD) -- 245; 781
- burns -- 612; 653; 657; 659; 703
- cachexia (wasting) -- 257
- cancer, acute myelogenous leukemia (AML) -- 118; 169
- cancer, bladder -- 219; 407; 408; 409; 410
- cancer, brain -- 217; 416
- cancer, breast -- 179
- cancer, chronic lymphocytic leukemia (CLL) -- 119; 761; 764; 769; 769; 945
- cancer, colorectal -- 121; 128; 129; 130; 219; 244; 275; 307; 314; 315
- cancer, cutaneous T-cell lymphoma -- 220
- cancer, gastrinoma diagnosis -- 935; 936
- cancer, hairy cell leukemia -- 204; 206
- cancer, head and neck -- 128
- cancer, Hodgkin's lymphoma -- 169; 171
- cancer, Kaposi's sarcoma -- 204; 206
- cancer, Li-Fraumeni Syndrome -- 233
- cancer, melanoma -- 206; 218; 219; 219; 796; 945
- cancer, melanoma radiodiagnostic imaging -- 309
- cancer, mesothelioma -- 628
- cancer, non-Hodgkin's lymphoma -- 115; 117; 169; 171; 206; 220; 306; 611
- cancer, non-Hodgkin's Lymphoma (NHL) -- 417
- cancer, ovarian -- 314
- cancer, ovarian radiodiagnostic imaging -- 302
- cancer prophylaxis, skin cancer -- 260
- cancer, prostate -- 242; 312
- cancer radiodiagnosis -- 121; 262; 302; 311; 314; 315
- cancer, rectum carcinoma -- 275
- cancer, renal cell carcinoma -- 218; 219; 219
- cancer, small cell lung cancer -- 311
- cancer, squamous cell carcinoma -- 232; 233
- cancer, thyroid -- 262
- cancer treatment, abdominal -- 131
- cancer treatment adverse effects -- 112; 133; 134; 135; 136; 137; 139; 140; 143; 158; 159; 160; 169; 170; 171; 216; 226; 272; 701; 802
- cancer treatment, gastric cancer -- 131
- cancer treatment, ovarian -- 131
- cancer treatment, thyroid cancer -- 262
- cancer vaccines -- 183; 184; 185; 242; 412
- candidiais -- 173
- cardiopulmonary bypass surgery -- 102; 225; 703; 713; 737; 738
- cardiovascular -- 181; 240; 268; 269; 270; 310; 606; 624; 625; 626; 627; 703; 934
- Castleman's disease -- 223
- catheter clearance -- 153; 269; 626; 627
- CD34+ stem cell enrichment -- 701
- cervical cancer prophylactic vaccines -- 183; 184; 185
- cervical, cervical -- 184; 185
- cervical dystonia -- 601; 603; 604
- cervicitis -- 614
- chicken pox prophylaxis -- 494; 564
- cholangiopancreatography -- 935; 936
- cholera prophylaxis -- 414; 415
- chronic fatigue syndrome -- 795
- chronic granulomatous disease (CGD) -- 213
- chronic heart failure (CHF) -- 231
- chronic lymphocytic leukemia (CLL) -- 119; 761; 764; 769; 945
- chronic myelogenous leukemia (CML) -- 796
- chronic renal failure -- 132; 133; 134; 135; 136; 137; 139; 140; 141; 142; 143
- colitis, ulcerative -- 264
- colon cancer -- 275
- colorectal cancer -- 128; 244
- colorectal cancer radiodiagnosis -- 121; 314
- complement C1 esterase inhibitor deficiency -- 113; 714
- complement system -- 120
- condyloma acuminata -- 184; 206; 795
- congenital heart disease -- 245
- congenital sucrase-isomaltase deficiency (CSID) -- 629
- controlled ovarian stimulation (COS) -- 122
- coral snake bites -- 910
- coronary angioplasty, percutaneous tranluminal (PTCA) -- 240
- Crohn's disease -- 169; 203; 264; 266
- cryopyrin-associated periodic syndromes (CAPS) -- 215
- cystic fibrosis (CF) -- 126
- cytomegalovirus (CMV) prophylaxis/retinitis -- 219; 748; 749; 946
- deep vein thrombosis (DVT) -- 102
- degenerative disc disease (DDD) -- 108
- delayed-hypersensitivity (DH) -- 932
- dermal filler -- 928; 929
- diabetes -- 192; 193; 194; 195; 197; 198; 199; 630; 632; 633
- diabetic foot ulcers -- 127; 239; 651; 652
- diabetic retinopathy (DME) -- 949
- dialysis patients, hepatitis B vaccination -- 177
- dialysis patients, Staphylococcus aureus vaccination -- 542
- diarrhea, travelerÕs -- 415
- digitalis poisoning -- 913; 914; 915
- diphtheria prophylaxis -- 418; 419; 421; 424; 425; 426; 427; 429; 430; 431; 432; 433; 434; 435; 436; 437; 438; 439; 440; 442; 443; 444; 445; 446; 447; 448; 449; 450; 451; 452; 555; 556; 557; 558; 559; 916
- diphtheria treatment -- 916
- disc prolapse -- 742
- disseminated intravascular coagulation (DIC) -- 243
- DNA repair -- 260
- dsDNA antibody inhibition -- 948
- elastase inhibition -- 709; 710; 711; 712
- emphysema -- 709; 710; 711; 712
- endoscopic retrograde cholangiopancreatography (ERCP) -- 935
- enterotoxigenic E. coli (ETEC) prophylaxis -- 415
- enzyme replacement therapy (ERT) -- 105; 126; 161; 167; 168; 187; 605; 607; 608; 609; 610; 611; 615; 629
- epidermolysis bullosa (EB) -- 656
- epidermolysis bullosa (RDEB), recessive dystrophic -- 656
- erythema multiforme (EM) -- 656
- extracorporeal plasma filtration -- 700
- extravasation, intradermal fluids -- 186; 616; 617; 618; 619
- Fabry disease -- 161; 162; 163
- facial wrinkles and folds -- 601; 602; 604; 924; 929
- Factor IX inhibitors -- 145
- Factor VII deficiency -- 728
- Factor VIII inhibitors -- 145; 728; 901
- Familial Cold Autoinflammatory Syndrome (FCAS) -- 215
- fistulas -- 264
- folate antagonist toxicity -- 112
- follicular maturation -- 172
- follicular non-Hodgkin's Lymphoma (NHL) -- 417
- gastric cancer treatment -- 131
- gastrinoma diagnosis -- 935; 936
- Gaucher disease -- 167; 615
- gene therapy -- 232
- genetic diseases -- 102; 105; 113; 120; 126; 144; 145; 146; 147; 148; 149; 150; 151; 152; 168; 187; 213; 215; 225; 233; 247; 250; 251; 252; 253; 254; 256; 257; 260; 605; 607; 608; 609; 611; 629; 656; 704; 705; 706; 707; 708; 709; 710; 711; 712; 714; 715; 716; 716; 717; 718; 719; 720; 721; 722; 723; 724; 725; 726; 727; 728; 730; 731; 733; 734; 739; 743; 761; 767; 798; 804; 901
- genital warts -- 206; 795
- genital warts prophylactic vaccines -- 183; 184
- glabellar lines/folds -- 601; 602; 604; 924
- glioblastoma multiformes (GBMs) -- 217; 416
- glycogenosis type II (GSD II) -- 168
- glycoprotein (GP)IIb/IIIa receptor inhibition -- 240
- gout -- 273
- growth hormone deficiencies -- 201; 202; 248; 249; 250; 251; 252; 253; 254; 255; 256; 257; 258
- growth hormone insensitivity syndrome (GHIS) -- 201; 202
- Guillain Barre Syndrome -- 761
- Haemophilus influenzae b prophylaxis -- 439; 440; 443; 445; 451; 452; 453; 454; 455; 456; 457; 458; 459; 460
- hairy cell leukemia -- 204; 206; 796
- hantavirus infection -- 219
- head and neck cancer -- 232; 233
- head cancer -- 128
- heart failure, acute (CHF) -- 231
- heart failure (CHF), congestive, acutely decompensated -- 231
- hemoglobinopathies -- 806
- hemoglobinuria, paroxysmal nocturnal -- 120
- hemolytic disease of the newborn (HDN) -- 703; 776; 777; 778; 779; 780
- hemophilia A -- 145; 147; 148; 149; 150; 151; 152; 700; 704; 705; 716; 717; 718; 719; 720; 721; 722; 723; 724; 725; 726; 727; 739; 805; 901
- hemophilia, acquired -- 145
- hemophilia B -- 144; 700; 704; 728; 730; 731; 732; 733; 734; 798; 805
- hemorrhage, acute intracerebral -- 145
- hemorrhage, intraocular -- 186; 619
- hemostatic agents -- 261; 619; 713; 714; 735; 736; 737; 738; 739; 798; 799; 802; 803; 807; 808; 900; 919; 920; 921; 921; 922; 923; 928
- heparin-induced thrombocytopenia (HIT) -- 181; 934
- hepatitis A prophylaxis -- 461; 462; 463; 464; 465; 466; 467; 758
- hepatitis B, chronic -- 205
- hepatitis B prophylaxis -- 174; 175; 176; 177; 178; 428; 438; 439; 440; 441; 442; 452; 460; 466; 468; 469; 754; 755; 756
- hepatitis C, chronic -- 204; 205; 206; 207; 207; 208; 209; 219; 794; 796
- hereditary angioedema (HAE) -- 113; 225; 714
- herpes simplex virus (HSV) infections -- 219
- herpes zoster prophylaxis -- 565
- hip replacement surgery -- 182
- HIV-infection -- 133; 136; 765; 933
- HLA alloimmunization -- 802
- human papillomavirus (HPV) vaccines -- 183; 184; 185
- Hunter syndrome -- 188
- Hurler-Scheie syndrome -- 187
- hydration, under the skin -- 186; 617; 618; 619
- hypercalcemia -- 110
- hyperglycemia -- 192; 193; 194; 195; 196; 197; 198; 199; 630; 631; 632; 633
- hyperhydrosis, axillary -- 601
- hyperuricemia -- 273
- hyperuricemia, cancer-associated -- 272
- hypoalbuminemia -- 703
- hypodermoclysis -- 186; 617; 618; 619
- hypogammaglobulinemia -- 761; 768; 771
- hypoglycemia -- 164; 165; 166; 192; 193; 195; 196; 198; 199; 630; 632; 633
- hypopituitarism -- 250; 252
- hypovolemia -- 703
- idiopathic pulmonary fibrosis (IPF) -- 213
- idiopathic thrombocytopenic purpura (ITP) -- 700; 760; 761; 761; 762; 763; 764; 765; 767; 769; 769; 770; 778; 801
- immune deficiencies, primary -- 743; 758; 760; 761; 762; 763; 764; 765; 766; 767; 768; 769; 770; 771; 772
- immune modulator -- 947
- immunodeficiency, secondary -- 219
- in vitro fertilization (IVF) -- 122; 186; 616; 617; 619
- infections, radiodiagnosis -- 305
- infertility treatment -- 122; 155; 156; 157; 172; 228
- inflammation, erysipelatous -- 219
- inflammation treatment -- 225; 713; 742
- influenza, avian/pandemic prophylaxis -- 484; 485; 486; 487; 488
- influenza prophylaxis -- 190; 191; 470; 471; 472; 473; 474; 475; 476; 477; 478; 479; 480; 482; 483
- inhalation delivery -- 194
- insulin-like growth factor (IGF-1) deficiency -- 201; 202
- interferon resistance treatment -- 796
- intestinal motility -- 165
- intracytoplasmic sperm injection (ICSI) -- 122; 186; 616; 617; 619
- isolated limb perfusion (ILP) -- 263
- Japanese encephalitis prophylaxis -- 224; 489
- juvenile idiopathic arthritis -- 223
- Kaposi's sarcoma -- 204; 206
- Kawasaki Syndrome -- 761; 761; 764; 767
- kidney disease -- 801
- knee cartilage repair -- 650
- knee lubrication -- 926; 927; 928; 930
- Laron Syndrome -- 201; 202
- leukemia, acute lymphoblastic (ALL) -- 169; 170; 171; 608; 609; 611
- leukemia, acute myelogenous (AML) -- 118; 169; 170; 171
- leukemia, chronic myelogenous (CML) -- 796
- leukemia, hairy cell -- 204; 206; 796
- leukopenia -- 169; 170; 171
- Li-Fraumeni Syndrome cancers -- 233
- liver transplantation, hepatitis B prophylaxis -- 755
- Lou GehrigÕs disease -- 200
- lung cancer, non-small cell lung cancer (NSCLC) -- 275
- Lyme disease prophylaxis -- 229; 230
- lymphoma, cutaneous T-cell -- 220
- lymphoma, Hodgkin's -- 169; 171
- lymphoma, indolent -- 115
- lymphoma, non-Hodgkin's (NHL) -- 115; 117; 169; 171; 206; 220; 271; 306; 611
- lysosomal storage diseases -- 105; 161; 167; 168; 187; 188; 615
- macular degeneration (AMD), age-related -- 275; 276; 949
- Maroteaux-Lamy syndrome -- 105
- measles prophylaxis -- 491; 492; 493; 494; 495; 496; 534; 758
- melanoma -- 124; 125; 206; 218; 219; 219; 796; 945
- melanoma prophylaxis -- 260
- melanoma radiodiagnostic imaging -- 309; 309
- meningitis prophylaxis -- 452; 497; 498; 499; 500; 501; 502; 503
- meningococcemia -- 106
- mesothelioma -- 628
- methotrexate toxicity -- 112; 747
- Muckle-Wells Syndrome (MWS) -- 215
- mucopolysaccharidosis I (MPS I) -- 187
- mucopolysaccharidosis II (MPS II) -- 188
- mucopolysaccharidosis VI (MPS VI) -- 105
- mucositis, oral -- 226
- multiple sclerosis (MS) -- 203; 210; 211; 212; 222
- mumps prophylaxis -- 492; 493; 494; 504; 534
- mumps skin testing -- 932
- mycosis -- 219
- myeloma -- 761
- myocardial infarction radiodiagnosis -- 310
- nasal administration -- 110; 190; 191; 486
- nasal surgery -- 928
- nasolabial folds (see also facial wrinkles and folds) -- 929
- neck cancer -- 128; 232; 233
- neonatal onset multisystem inflammatory disease (NOMID) -- 215
- nephritis, membranous -- 120
- nephrosis -- 703
- nephrotoxicity -- 112
- nerve root inflammation -- 742
- neuromuscular blocking -- 600; 601; 602; 603; 604
- neutropenia -- 158; 159
- neutropenia -- 160
- non-HodgkinÕs lymphoma (NHL) -- 114; 115; 117; 169; 171; 206; 220; 271; 306; 417; 611
- non-small cell lung cancer (NSCLC) -- 275
- oleander poisoning -- 914
- ophthalmic disease -- 949
- ophthalmic surgery -- 186; 616; 617; 618; 619
- oral mucositis -- 226
- osteoarthritis -- 650; 742; 926; 927; 928; 930
- osteomyelitis -- 219
- osteoporosis -- 110; 234; 235
- ovarian cancer -- 301
- ovarian cancer radiodiagnostic imaging -- 302; 302
- ovarian cancer treatment -- 131
- ovary follicle stimulation -- 155; 156; 157; 228
- PagetÕs disease -- 110
- pancreatic cancer -- 111
- pancreatic function diagnosis -- 935; 936
- pancreatitis -- 219
- paraproteinemic conditions -- 801
- paroxysmal nocturnal hemoglobinuria (PNH) -- 120
- percutaneous coronary intervention -- 934
- percutaneous transluminal coronary angioplasty (PTCA) -- 934
- periodontal bone repair -- 237; 931
- peripheral arterial occlusion (PAO) -- 153
- peritonitis -- 219
- pertussis prophylaxis -- 236; 429; 430; 431; 432; 433; 434; 435; 436; 437; 439; 440; 441; 442; 443; 444; 445; 446; 447; 448; 449; 450; 451; 452; 505; 506; 507; 508; 509; 510
- plague prophylaxis -- 511
- plasmapheresis -- 700
- plasmapheresis, therapeutic -- 801
- plastic surgery -- 924; 929
- platelet aggregation inhibition -- 240
- pneumococcal infection prophylaxis -- 513; 514; 515
- polio prophylaxis -- 439; 440; 441; 442; 516; 517; 518; 519; 520; 521
- polydystrophic dwarfism -- 105
- Pompe disease -- 168
- porphyria, acute intermittent -- 716
- positive-pressure convection-enhanced delivery (CED) -- 217
- post-herpetic neuralgia treatment -- 565
- Prader-Willi syndrome (PWS) -- 254
- prostate cancer treatment -- 242
- prostate carcinoma radiodiagnosis -- 312
- Protein C deficiency -- 804
- prothrombin complex deficiency -- 805
- psoriasis -- 114; 227
- psoriatic arthritis -- 264; 265; 267
- pulmonary embolism -- 626; 627
- purpura fulminans -- 804
- pyelonephritis -- 219
- pyoderma -- 219
- rabies prophylaxis/treatment -- 525; 526; 527; 528; 529; 773; 774; 775
- radicular lumbar syndrome -- 742
- radiodiagnostic aid (digestive) -- 164; 165; 166
- radioimmune therapy -- 117; 306
- rattlesnake bites -- 908
- recessive dystrophic epidermolysis bullosa (RDEB) -- 656
- recombinant DNA -- 215
- rectal cancer -- 275
- rejection, heart transplants -- 303
- rejection, kidney transplants -- 221; 222; 303; 917; 918
- rejection, liver transplants -- 303
- rejection, transplants -- 221; 222
- renal cell carcinoma -- 219
- renal cell carcinoma (RCC) -- 218; 219
- renal insufficiency, chronic -- 250
- renal transplantation -- 221; 222; 303; 917; 918
- respiratory distress syndrome (RDS) -- 941; 942; 943
- respiratory infections, bacterial -- 406
- respiratory syncytial virus (RSV) prophylaxis -- 245; 246; 781; 782
- respiratory syncytial virus (RSV) treatment -- 782
- rheumatoid arthritis -- 223
- rheumatoid arthritis (RA) -- 114; 115; 123; 214; 264; 265; 266; 267; 700
- Rho(D) isoimmunization -- 777; 778; 779; 780
- rotavirus prophylaxis -- 530; 531; 532
- rubella prophylaxis -- 493; 494; 495; 496; 533; 534; 758
- scars -- 924
- Scheie syndrome -- 187
- sealant, hemostatic -- 261; 736; 737; 738; 739; 808; 809; 920; 922
- sepsis -- 106; 219; 243
- severe combined immunodeficiency (SCID) -- 760; 761; 765; 766; 767; 768
- shingles prophylaxis -- 565
- shock, hypovolumic -- 806
- short bowel syndrome -- 257
- silica matrix-Protein A -- 700
- single photon emission computed tomography (SPECT) -- 312
- sinus filling -- 928
- sinusitis -- 219
- skin damage ultraviolet light -- 260
- skin damage, ultraviolet light -- 260
- skin grafts, autologous -- 653; 654; 656
- skin grafts, heterologous -- 651
- skin lines/folds (see also facial wrinkles and folds) -- 924
- skin necrosis, coumarin induced -- 804
- skin ulcers -- 239; 612; 614; 651; 654
- small cell lung cancer radiodiagnosis -- 311
- smallpox prophylaxis -- 535; 536; 537; 538; 539; 540; 541
- smallpox vaccine adverse effects -- 788; 789; 790
- snake venom poisoning -- 907; 908; 909; 910
- somatotropin antagonists -- 259
- spasmodic torticollis -- 603
- spinal fusion -- 108; 109
- spreading agent -- 186; 616; 617; 618; 619
- squamous cell carcinoma, head and neck -- 232; 233
- squamous cell carcinoma of the head and neck (SCCHN) -- 128
- Staphylococcus aureus infections -- 783
- Staphylococcus aureus prophylaxis -- 542
- stem cell enrichment, autologous -- 701
- stem cell transplants -- 171
- Stevens-Johnson syndrome (SJS) -- 656
- strabismus -- 601; 602
- Streptococcus pneumoniae prophylaxis -- 513; 514; 515
- stroke, acute ischemic -- 269
- surgery, intraocular -- 186; 616; 617; 926
- surgery, limb tumors -- 263
- sutures -- 241
- sutures, sealing -- 900
- sweating, underarm -- 601
- systemic inflammatory response syndrome (SIRS) -- 713
- systemic lupus erythematosus (SLE) -- 948
- T-cell co-stimulation modulators -- 123; 124; 124; 125
- teeth reattachment -- 237; 931
- tetanus prophylaxis -- 421; 423; 424; 425; 426; 427; 428; 429; 430; 431; 432; 433; 434; 435; 436; 437; 438; 439; 441; 442; 443; 444; 445; 446; 447; 448; 449; 450; 451; 452; 543; 544; 545; 546; 547; 548; 549; 550; 551; 552; 553; 554; 555; 556; 557; 558; 559; 784; 785; 786; 787
- thoracic aortic dissection repair -- 900
- thrombin inhibition -- 180; 181; 182; 934
- thrombocytopenia (see also ITP entries) -- 216; 802; 803
- thromboembolism -- 102; 706; 707; 708
- thrombosis, deep-vein -- 182
- thrombotic thrombocytopenic purpura (TTP) -- 798
- thyroglobulin (Tg), serum testing -- 262
- thyroid cancer, radiodiagnosis -- 262
- thyroid cancer, treatment -- 262
- tibia fracture repair -- 108; 109
- tissue hypoxia -- 949
- toleragens -- 948
- toxic epidermal necrolysis (TEN) -- 656
- transfusion reactions, recurrent febrile -- 802
- transplants (see also rejection) -- 222; 748; 749
- tuberculosis -- 219
- tuberculosis prophylaxis -- 407; 411; 412
- tumor lysis syndrome (TLS) -- 272
- Turner syndrome -- 249; 250; 252
- typhoid fever prophylaxis -- 467; 561; 562; 563
- ulcerative colitis -- 264
- urography, subcutaneous -- 186; 616; 617; 618; 619
- vaccination, prime-boost -- 541
- vaccinia virus infection prophylaxis -- 788; 789; 790
- vaginitis -- 614
- varicella-zoster virus infection prophylaxis -- 494; 564; 565; 758; 791; 792
- variola virus prophylaxis -- 535; 536; 537; 538; 539; 540; 541
- vermilion borders -- 924
- Vibrio cholerae prophylaxis -- 414; 415
- vitreous hemorrhage (eye) -- 186; 619
- vitronectin receptor inhibition -- 240
- von Willebrand's disease (vWD) -- 716; 726
- West Nile virus (WNV) -- 769
- Wiskott-Aldrich syndrome -- 760; 761; 765; 766; 767; 768
- wound coverings, skin -- 651; 653; 656; 657; 658; 659
- wound debridement -- 612; 614; 622
- wound healing (see also skin entries) -- 931
- x-linked immunodeficiency -- 760; 765; 766; 767
- xeroderma pigmentosum -- 260
- yellow fever prophylaxis -- 566; 567
- Yersinia pestis prophylaxis -- 511
- Yersinia pestis treatment -- 219
- Zollinger-Ellison Syndrome (ZES) diagnosis -- 935; 936